A clinical trial on ayavathi chooranam in the management of deepana silethma noi(dyslipidemia)

A prospective open labelled, single arm, non - randomized, single centric, phase II clinical trial to determine the effectiveness of ayavathi chooranam in the management of deepana silethma noi (dyslipidemia) - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104392

Enrollment

Registered

2026-02-20

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

Intervention1: Ayavathi Chooranam: Dosage:1 varaganedai (4.2gram)twice a day for 48 days. Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosis of primary dyslipidemia 2.TC above 200 mg/dl, LDL above 130mg/dl, VLDL above 30mg/dl, TG above 200mg/dl 3.Having not taking any lipid lowering drugs for the past 1 month 4.Able to adhere to long term treatment 5.Willing and able to follow scheduled visit plan, diet and exercise instructions, lab tests and other procedures 6.Having voluntarily given their informed consent.

Exclusion criteria

Exclusion criteria: Combined with any cardiac disorders Combined with any liver disorders Renal disorders Pregnancy and lactating women Participated in any clinical trials of other drug in the past 4 weeks.

Design outcomes

Primary

Measure	Time frame
To determine the clinical efficacy of Ayavathi chooranam (internal) in the management of Deepana silethma noi (Dyslipidemia) and to evaluate the changes in LDL from baseline to week 12.Timepoint: 48 days	—

Secondary

Measure	Time frame
To collect various siddha literatures and modern journals for literature review on Deepana silethma noi. To study other cofactors related to disease like age, sex, dietary habits, family history and socioeconomic status. To evaluate pharmacological activities of ayavathi chooranam. To study about the prevalence of deepana silethma noi in relation with diet and lifestyle. To evaluate the siddha parameters (including envagai thervu, neerkuri, neikuri) during trial period. To evaluate modern parametric changes. To evaluate the change in serum TC, HDL at 48th day. To document biostatistical analysis.Timepoint: 6 months	—

Measure

Time frame

To collect various siddha literatures and modern journals for literature review on Deepana silethma noi. To study other cofactors related to disease like age, sex, dietary habits, family history and socioeconomic status. To evaluate pharmacological activities of ayavathi chooranam. To study about the prevalence of deepana silethma noi in relation with diet and lifestyle. To evaluate the siddha parameters (including envagai thervu, neerkuri, neikuri) during trial period. To evaluate modern parametric changes. To evaluate the change in serum TC, HDL at 48th day. To document biostatistical analysis.Timepoint: 6 months

—

Countries

India

Contacts

Public ContactDr S Justus Antony MD S

Government Siddha Medical College and Hospital

sukgsmc2014@gmail.com7598253499

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026